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Wolbachia are intracellular maternally inherited bacteria that can spread through insect
populations and block virus transmission by mosquitoes, providing an important approach to
dengue control. To better understand the mechanisms of virus inhibition, we here perform
proteomic quantiﬁcation of the effects of Wolbachia in Aedes aegypti mosquito cells and
midgut. Perturbations are observed in vesicular trafﬁcking, lipid metabolism and in the
endoplasmic reticulum that could impact viral entry and replication. Wolbachia-infected cells
display a differential cholesterol proﬁle, including elevated levels of esteriﬁed cholesterol, that
is consistent with perturbed intracellular cholesterol trafﬁcking. Cyclodextrins have been
shown to reverse lipid accumulation defects in cells with disrupted cholesterol homeostasis.
Treatment of Wolbachia-infected Ae. aegypti cells with 2-hydroxypropyl-β-cyclodextrin
restores dengue replication in Wolbachia-carrying cells, suggesting dengue is inhibited in
Wolbachia-infected cells by localised cholesterol accumulation. These results demonstrate
parallels between the cellular Wolbachia viral inhibition phenotype and lipid storage genetic
disorders.
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Wolbachia are intracellular endosymbiotic bacteria ofinvertebrates that are maternally transmitted. Theycan manipulate host reproduction to allow rapid
population spread, especially using cytoplasmic incompatibility, a
crossing sterility that can provide a reproductive advantage to
females carrying the bacteria1. In certain host-strain combina-
tions where high bacterial densities are reached, Wolbachia can
signiﬁcantly reduce the transmission of some of the most
important mosquito-borne pathogens of humans including den-
gue virus (DENV) and chikungunya virus2–13. The wMel strain
has been taken to very high population frequency in wild
populations of Aedes aegypti in ﬁeld trials14, and is now being
deployed on a larger scale in a number of countries for dengue
control. It is important to gain a full understanding of the
mechanisms by which Wolbachia inhibit arbovirus transmission,
in order to be able to maximise the effectiveness and longevity of
its use in dengue control—in particular, to be able to rapidly
understand, and react effectively to, any operational failures that
may arise over time.
Possible contributory factors to the phenotype include immune
activation and elevated reactive oxygen species as observed in
Ae. aegypti4, 15, but virus inhibition can apparently occur without
observable immune activation in Ae. albopictus16 and Droso-
phila17. Wolbachia likely incorporate cholesterol into their
membranes as a substitute for lipopolysaccharide18, 19, and it has
been hypothesised based on Drosophila data that direct compe-
tition between the bacterium and viruses for this resource may be
responsible for the dengue transmission-blocking phenotype20,
although no supporting evidence in mosquitoes has to date been
presented.
To characterise the effects of a high-density virus-blocking
Wolbachia infection in Ae. aegypti and detect changes in host
cellular pathways that may play a role in limiting viral replication,
we performed a quantitative proteomics analysis of wMelPop
versus uninfected Aag2 cells. We detected perturbations in vesi-
cular trafﬁcking, the endoplasmic reticulum (ER) and lipid
metabolism associated with Wolbachia infection. Differential
expression of key proteins involved in cholesterol homeostasis
indicated that Wolbachia-infected cells experience localised cho-
lesterol accumulation and a defect in intracellular cholesterol
transport. Treating Wolbachia-infected cells with 2-
hydroxypropyl-β-cyclodextrin, used to restore cholesterol
Table 1 Presence of Wolbachia causes differential expression of host proteins with roles in the unfolded protein response,
vesicular trafﬁcking, lipid metabolism and autophagy
ER/unfolded protein response
UDP-glycosyltransferase family 2.12
UDP-glycosyltransferase family 1.98
Subunit of the N-oligosaccharyl transferase complex 1.78
Thioredoxin/protein disulfide isomerase 1.75
Poly polymerase 16 1.72
Putative udp-glucuronosyl and udp-glucosyl transferase 1.63
Oligosaccharyl transferase  1.51
Oligosaccharyl transferase 1.42
Truncated ER mannose-binding lectin 1.41
1.37
Putative calnexin 99a 1.35
Anoctamin 0.19
Lipid metabolism
Apolipoprotein D 5.42
Niemann-Pick type C-2e (NPC2)/ML33 2.90
Putative lipid exporter abca1 (AAEL012701) 2.84
Putative lipid exporter abca1 (AAEL015146) 2.65
Saposin 1.79
Putative peroxisomal phytanoyl-coa hydroxylase 1.74
Putative fatty acid desaturase 1.67
Putative microsomal triglyceride transfer protein 1.62
Putative mitochondrial fatty acid anion carrier  1.45
Putative lipid particle 1.39
Fatty acid synthase 0.75
Protein phosphatase 5 0.74
Acetyl-coa carboxylase 0.69
Allergen, putative 0.60
Low-density lipoprotein receptor (ldl) 0.42
Vesicular trafficking
Putative lysosomal protein ncu-g1 2.72
Putative snare protein pep12/vam3/syntaxin 7/syntaxin 17 2.43
Wurst 1.83
Mucolipin-3 1.62
Vacuolar sorting protein 1.54
Putative rush hour 1.40
Syntenin 1.35
Rabkinesin-6 0.74
Tomosyn 0.70
n-myc downstream regulated (ndrg1)  0.67
myosin V 0.54
Autophagy
Vacuolar ATP synthase subunit c 0.75
Putative cysteine protease required for autophagy (ATG4B) 0.67
Tuberous sclerosis complex 2 (TSC2) 0.45
Fold change w MelPop/-ve
Putative translocon-associated complex trap gamma subunit 
Proteins in an Ae. aegypti cell line infected with wMelPop were quantiﬁed relative to uninfected cells. Fold changes in wMelPop relative to uninfected cells are coloured according to increased (blue) or
decreased (red) levels
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homeostasis in Niemann–Pick type C cells, rescued dengue virus
replication. This suggested some similarities between Wolbachia
infection and human lipid storage disorders such as
Niemann–Pick type C.
Results
Proteomic analysis of Wolbachia-infected cells. To characterise
the effect of Wolbachia infection on the host, we carried out a
quantitative proteomic analysis of uninfected and wMelPop-
infected Ae. aegypti cells. In the wMelPop-carrying cell line, dif-
ferential expression of 265 host proteins was observed compared
to Wolbachia-free cells (Table 1, Supplementary Fig. 1, Supple-
mentary Tables 1 and 2 and Supplementary Datas 1, 2). Pertur-
bations in vesicular trafﬁcking, the ER as well as alterations in
lipid/cholesterol metabolism were particularly notable in Wol-
bachia-infected cells (Table 1). Differential expression of several
host proteins involved in lipid metabolism was detected including
upregulation of fatty acid desaturase, which would compensate
for the uptake of unsaturated fatty acids by Wolbachia, and
proteins involved in catabolisis of fatty acids (saposin, phytanoyl-
CoA hydroxylase). Conversely, fatty acid synthase was down-
regulated; in the presence of DENV, fatty acid synthase is upre-
gulated and required for efﬁcient replication21, and hence this
change is likely to be antagonistic to DENV replication (Sup-
plementary Table 2).
A lysosomal protein (ncu-g1) and syntaxin-17 (involved in
autophagosome–lysosome fusion) and regulators of endocytosis
(wurst and rush hour) were all upregulated in the presence of
Wolbachia, while two proteins involved in exocytosis and ER to
Golgi transport (rabkinesin-6 and tomosyn) were downregulated
(Supplementary Table 2). Further evidence for perturbations in
vesicular trafﬁcking were observed as alterations in the levels of
mucolipin-3, vacuolar sorting protein, syntenin, ndrg1 and
myosin V (Fig. 1). Decreased levels of the V-ATPase regulatory
subunit c in Wolbachia-infected cells could affect clathrin-
mediated endocytosis and endosomal acidiﬁcation, which are
critical for DENV entry22. Autophagy, the homeostatic process of
encapsulation of cytoplasmic components in double-membrane
vesicles for degradation, appears to be suppressed in Wolbachia-
infected cells since ATG4B and TSC2 are downregulated.
Autophagy is activated and required by DENV for triglyceride
release from storage in cytoplasmic lipid droplets to provide
energy for replication via β-oxidation21, a subversion of its usual
anti-pathogen role. In contrast,Wolbachia density can be reduced
by autophagy activation23, providing a selective pressure on the
bacterium to suppress this pathway, with a probable antiviral side
effect. Two lysosomal proteins, ncu-g1 and saposin, were
upregulated, which may be due to the inhibition of autophagy
causing an accumulation of lysosomes.
ER proteins with roles in protein folding and glycosylation
were upregulated in Wolbachia-infected cells (Table 1), suggest-
ing the presence of ER stress and triggering of the unfolded
protein response, a pathway aimed at increasing protein folding
capacity to restore ER homeostasis24. Members of the uridine
diphosphate glycosyltransferase family were upregulated, which
play an important role in quality control of glycoproteins in the
ER25. Components of the oligosaccharyltransferase complex were
upregulated in Wolbachia-infected cells, involved in the co-
translational glycosylation of proteins as they enter the ER26.
A major ER calcium-dependent chaperone, calnexin 99a, was
upregulated as well as a protein disulﬁde isomerase, indicating a
cellular attempt to increase protein folding activity.
Several proteins that are known to respond to changes in
cholesterol or play a role in cholesterol metabolism were
differentially regulated. Apolipoprotein D and ABCA1 (cholesterol
efﬂux) and a homologue of cholesterol transporter NPC2 were
upregulated in the presence of Wolbachia, while the low-density
lipoprotein (LDL) receptor (cholesterol import) was downregulated
(Supplementary Table 2). When cells sense an excess of cholesterol,
the LDL receptor and fatty acid synthase are downregulated and
cholesterol efﬂux transporters are upregulated. In human
Niemann–Pick disease, cholesterol and/or sphingolipids accumulate
in late endosomes/lysosomes due to mutations in the intracellular
cholesterol transport proteins NPC1 or NPC227, and is accom-
panied by an increase in Apolipoprotein D expression. These
cellular responses to cholesterol accumulation/overload mirror the
protein expression changes observed in Wolbachia-infected cells,
consistent with the host cell experiencing a defect in intracellular
cholesterol transport.
Perturbed cholesterol homeostasis in Wolbachia-infected cells.
Based on the proteomic results, cholesterol levels were measured
and Wolbachia-infected cells were found to contain ~100% more
esteriﬁed cholesterol compared to uninfected cells (Fig. 1a,
0
100
200
300
400
500
DMSO cholesterol cholesterolDMSO
–ve wMelPop
FF
U/
m
l
0
100
200
300
400
500
Esterified Free Total
µg
 c
ho
le
st
er
ol
/m
g 
pr
ot
ei
n
–ve wMelPop –ve wMelPop –ve wMelPop
0
50
100
*
*
******
a b
Fig. 1 Infection with Wolbachia is associated with elevated esteriﬁed cholesterol but lower free cholesterol. a Quantiﬁcation of esteriﬁed, free and total
cholesterol in uninfected (–ve) and wMelPop-infected Aag2 cells. Quantiﬁcation was performed on 12 biological replicates of each cell line. b DENV
replication in –ve or wMelPop-infected Aag2 cells. Cells were pretreated with DMSO or 50 µg/ml cholesterol for 48 h prior to infection with DENV at a
multiplicity of infection of 0.1. Cell culture supernatant was harvested 5 days post infection and DENV viral titre (ﬂuorescent focus units/ml) measured by
ﬂuorescent focus assay. Statistical signiﬁcance was determined with Student’s t-test, n= 5
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Fig. 2 Pretreatment of Wolbachia-infected Aag2 cells with low concentrations of 2-hydroxypropyl-β-cyclodextrin (2HPCD) reverses inhibition of DENV
replication. a Uninfected cells (–ve) and wMelPop-infected cells were treated for 48 h with various concentrations of 2HPCD prior to addition of DENV
virus at a multiplicity of infection of 0.1. Cells were harvested 5 days post infection and DENV levels measured by qPCR. Signiﬁcant differences of <0.05
are indicated as determined by analysis of variance (ANOVA) corrected by Tukey’s HSD test, n= 5. b Cholesterol turnover imaged using TopFluor
cholesterol. Uninfected and wMelPop-infected cells were pretreated with either PBS or 0.1 mM 2HPCD for 24 h. Cells were then labelled with TopFluor
cholesterol for 30min and subsequently incubated with either PBS or 0.1 mM 2HPCD for 24 h before imaging by ﬂuorescence confocal microscopy; scale
bar indicates 10 µm. Lipid droplets were quantiﬁed as TopFluor-positive spots/cell; error bars denote s.d. Statistical signiﬁcance was assessed by ANOVA
corrected by Tukey’s HSD test, n = 5. c Imaging of Nile Red stained or TopFluor-treated wMelPop cells and measurement of lipid droplet size
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p= 0.000022, Student’s t-test), although free cholesterol levels
were decreased by ~24% in Wolbachia-infected cells (p=
0.000047, Student’s t-test). Total cholesterol levels were ~9%
lower inWolbachia-infected cells (p= 0.032, Student’s t-test). The
increase in levels of esteriﬁed cholesterol in infected cells is
consistent with hypercholesterolaemia, since cholesteryl esters are
the primary storage and transport forms of cholesterol28. Sup-
plementation of Aag2 wMelPop cells with cholesterol did not
rescue DENV replication (Fig. 1b), while in uninfected Aag2 cells
cholesterol supplementation inhibited DENV replication, as
previously reported29.
Perturbed cholesterol homeostasis can cause ER stress30, but the
reverse is also true, with ER stress being associated with lipid
dysregulation and an increase in cellular lipid droplet content31. It is
therefore difﬁcult to precisely dissect the hierarchy of perturbations in
Wolbachia-infected cells; however, it is likely that both ER stress and
disrupted cholesterol homeostasis negatively impact DENV
replication.
There is evidence that cholesterol plays an important role in
entry of DENV and other ﬂaviviruses to mammalian cells and is
required in the DENV viral envelope29, 32; it is also likely that
they require particular lipid and cholesterol proﬁles for exit from
the cell33. Speciﬁc cellular cholesterol proﬁles are required by
arboviruses and both cholesterol depletion and excess can inhibit
DENV—the latter probably by changing membrane rigidity29.
The 2-hydroxypropyl-β-cyclodextrin (2HPCD) is a cholesterol-
binding agent routinely used to modulate cellular cholesterol
content34, depending on the cyclodextrin/cholesterol molar ratio,
ranging from cholesterol depletion to enrichment. At high
concentrations (>1 mM), it acts as a cholesterol sink and can
Table 2 Differentially expressed proteins with roles in the unfolded protein response, vesicular trafﬁcking, lipid metabolism and
autophagy in wMel-infected vs. wt Aedes aegypti midguts
ER/unfolded protein response
1.36
1.26
1.21
1.21
1.21
1.2 
1.16
1.16
1.16
1.13
1.12
1.11
1.09
1.09
0.91
Lipid metabolism
Niemann-Pick type C2 (AAEL015136) 2.3 
Niemann-Pick type C2 (AAEL009760) 2.06
Sterol carrier protein 2-like 2  1.85
Niemann-pick C1  1.35
Palmitoyltransferase 1.33
Lipid droplet associated hydrolase 1.33
Sterol carrier protein 2-like 3 variant 1  1.27
Putative oxysterol binding protein  1.24
Phosphoacetylglucosamine mutase  1.21
Putative  very long-chain acyl-coa synthetase/fatty acid transporter  1.17
Glycerol-3-phosphate acyltransferase 3-like 1.15
Putative 85 kDa calcium-independent phospholipase a2 1.13
Putative lipid particle  0.89
Sterol carrier protein-X  0.88
Acyl-coenzyme A oxidase 0.88
Putative fatty acid desaturase  0.82
Vesicular trafficking
Putative syntaxin 1a  1.29
Putative golgi protein  1.24
Putative neurobeachin  1.15
Vesicle protein sorting-associated  1.15
Use1  1.13
Putative vesicle coat complex copi alpha subunit 1.07
Putative nipsnap 0.81
Autophagy
Putative puromycin sensitive aminopeptidease  1.22
Rabconnectin  1.06
Vacuolar H+-ATPase V1 sector subunit D 0.92
Cathepsin L 0.85
Fold change w Mel/-ve
Vacuolar ATPase assembly integral membrane protein 
Alpha-glucosidase  
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit stt3b
olichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 
tRNA-splicing ligase RtcB 
Putative mannose lectin ergic-53  
Putative calnexin 99a  
Putative yip1 
Reticulon-like protein 
Putative proteasome non-atpase 26s subunit  
Putative sec23-binding domain of sec16  
Heat shock protein  
Peptidylprolyl isomerase 
Putative transport and golgi organization protein 1  
Gp210  
Fold changes in wMelPop relative to uninfected cells are coloured according to increased (blue) or decreased (red) levels
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extract cholesterol from membranes, while at lower concentra-
tions, it can also act as a cholesterol shuttle, transporting
cholesterol between membranes35–37. At lower concentrations
(<1 mM), 2HPCD shows efﬁcacy in the treatment of mouse
models of Niemann–Pick type C disease38, probably by releasing
trapped cholesterol into the cytosol33.
DENV rescue in Wolbachia-infected cells with 2HPCD. Our
results showed upregulation of a Niemann–Pick type C-related
protein and an accumulation of stored cholesterol in Wolbachia-
infected cells. 2HPCD was therefore added to Ae. aegypti cells,
and rescue of DENV replication in wMelPop-containing cells was
observed (Fig. 2a). In contrast, the same concentrations of
2HPCD strongly inhibited DENV in control Wolbachia-free Ae.
aegypti cells (Fig. 2a), in agreement with a previous study32.
Importantly, Wolbachia density was not signiﬁcantly affected by
the cyclodextrin treatment, thus ruling out a density-mediated
mechanism of rescue of inhibition (Supplementary Fig. 2).
2HPCD also rescued DENV replication in wMelPop-containing
cells at the infectious particle level (Supplementary Fig. 3). To
visualise cholesterol dynamics, pulse labelling of uninfected and
wMelPop-infected Aag2 cells with a ﬂuorescently labelled cho-
lesterol analogue was undertaken and the cells imaged 48 h later.
The wMelPop cells showed signiﬁcantly higher intracellular
accumulation of the ﬂuorescent cholesterol in large spots within
the cell (Fig. 2b), and this accumulation was reduced upon
2HPCD treatment. The labelled cholesterol did not colocalise
with the rab7 marker of late endosomes (Supplementary Fig. 4).
We hypothesised that TopFluor was localising to lipid droplets
due to the round shape and size of the spheres observed. In order
to determine if this was the case, we stained wMelPop cells with
the dye Nile Red. This dye speciﬁcally binds lipids and ﬂuoresces
green/yellow when binding neutral lipids such as those stored in
lipid droplets39. Comparison of the spheres observed under Nile
Red and TopFluor staining (Fig. 2c) indicate that TopFluor is
localising to lipid droplets. Further to this, three-dimensional
(3D) reconstruction of TopFluor labelled images showed, upon
2HPCD treatment, a clear diffusion of green ﬂuorescence
observed in wMelPop cells and not in negative cells, suggesting a
reduction in lipid droplet accumulation of TopFluor (Supple-
mentary Fig. 5).
Proteomic analysis of Wolbachia-infected Ae. aegypti midguts.
In order to examine whether similar Wolbachia-induced changes
could be observed in vivo, a quantitative proteomics analysis of
uninfected and wMel-infected Ae. aegypti midguts was per-
formed. The wMel strain is a less efﬁcient dengue blocker than
wMelPop and is maintained at a lower density, but is currently
the strain most commonly being utilised for ﬁeld releases5, 9–13.
As midguts are the ﬁrst tissue encountered by DENV following its
ingestion in a bloodmeal, anyWolbachia-associated perturbations
would signiﬁcantly impact on DENV replication and dis-
semination in the host. In total, 3,562 unique proteins were
quantiﬁed, of which 434 showed differential expression in wMel
vs. uninfected midguts (Table 2, Supplementary Table 3 and,
Supplementary Data 3). Wolbachia-associated changes were
observed in cholesterol homeostasis, ER proteins, vesicular traf-
ﬁcking and autophagy, suggesting similar perturbations were
induced by Wolbachia in the midguts and cell line (Table 2).
In wMel-carrying midguts there was upregulation of several
Niemann–Pick proteins and proteins involved in intracellular
sterol transport, with the exception of sterol carrier protein X,
which was downregulated. As observed in the cell line, several ER
proteins were upregulated including components of the oligo-
saccharyl transferase complex (stt3b, DAD1) and proteins
responsible for restoring ER homeostasis as part of the unfolded
protein response (RtcB, calnexin 99a, heat shock protein,
peptidylprolylisomerase). Interestingly, several secreted proteins
(trypsin 5G1, chymotrypsin-1, chymotrypsin-2, vitellogenin,
Supplementary Data 3) were upregulated in the Wolbachia-
carrying midguts. These proteins are normally upregulated
following a bloodmeal; their upregulation in non-blood-fed
Wolbachia-infected mosquitoes could be a result of a defect in
protein secretion, possibly as a result of altered ER homeostasis,
leading to intracellular accumulation. Elevated trypsin 5G1 prior
to a bloodmeal may further reduce DENV entry and replication
in the midgut40.
Several proteins whose human homologues are mutated in
lysosomal storage disorders were found to be upregulated in the
presence of Wolbachia, providing further evidence of perturbed
lipid metabolism/vesicular trafﬁcking (Supplementary Table 3).
In particular, sphingomyelin phosphodiesterases, enzymes deﬁ-
cient in Niemann–Pick disease type A41, were upregulated. These
data strongly suggest that the perturbations observed in the cell
line also occur in vivo, and also demonstrate that they are not
restricted to the wMelPop infection, which reaches unusually high
density and affects the transcription of an unusually large number
of host genes compared to lower-density virus-blocking Wolba-
chia infections42.
Discussion
A number of the proteins affected by the presence of Wolbachia
are mutated or deﬁcient in human lysosomal storage disorders
such as Niemann–Pick disease, suggesting some parallels between
these cellular states. As is thought to be the case in 2HPCD
treatment of the Niemann–Pick type C disorder, the cyclodextrin
treatment of Wolbachia-infected cells is likely to act as a shuttle
and release trapped cholesterol into the cytosol, facilitating virus
replication. Our data suggest Wolbachia-mediated inhibition
occurs early in the DENV replication cycle, consistent with a
recent study by Rainey et al.43.
Since lipids are degraded in late endosomes, perturbations in
vesicular trafﬁcking at this stage would likely manifest as a dys-
regulation of several lipid classes44, and manipulation of other
lipids should be further investigated in future work. Molloy
et al.45 performed lipidomic analysis of Wolbachia-infected Ae.
albopictus cells revealing depletion of ceramides and altered levels
of some sphingomyelin species. Data presented here suggest this
may be related to defects in late endosome processing of sphin-
gomyelin to ceramide. Wolbachia-infected cells showed an
upregulation of sphingomyelin phosphodiesterases, the enzyme
responsible for hydrolysing sphingomyelin to ceramide, indicat-
ing a host attempt to correct defects in late endosome lipid
processing and restore cellular homeostasis. Molloy et al.45 also
found that phosphatidylcholine and phosphatidylethanolamine
levels were strongly perturbed. Treatment of cells with U18666A
induces a Niemann–Pick type C-like phenotype, inhibits Dengue
replication and similarly causes dysregulation in phosphati-
dylcholine and phosphatidylethanolamine due to defects in late
endosome lipid trafﬁcking46.
In contrast to the Aedes data presented here, supplementation
with cholesterol reduced Wolbachia-mediated protection from
the pathogenic virus DCV in Drosophila and increased viral
replication20. Given that this virus is not related to the Flavivirus
DENV, there are likely to be differences in the mechanisms of cell
entry/replication and degree of cholesterol dependence that will
inﬂuence the interactions between virus, Wolbachia and host
cells. In addition, the effect of cholesterol supplementation on
DCV titre in uninfected Drosophila was not investigated in the
study of Caragata et al.20, making it unclear if the effect observed
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was a reversal of Wolbachia-mediated inhibition or a general
enhancement of viral replication. The differences observed
between Drosophila and Aedes could also be related to ﬂuctua-
tions in Wolbachia density following dietary cholesterol treat-
ment in Drosophila, rather than a direct effect20.
In both the Wolbachia-infected Ae. aegypti cell line and mid-
guts, perturbations were observed in the ER, vesicular trafﬁcking,
lipid metabolism and autophagy. The good overlap between the
two data sets at the level of pathways affected but not at the level
of individual differentially expressed proteins is likely due to the
different proteomic composition of a cell line vs. midguts and the
different lysis and quantitation methods used.
The detected ER perturbation in Wolbachia-infected cells is of
interest given that DENV uses the ER for synthesis and
maturation of proteins47 and data show close association of
Wolbachia with the ER membranes48. Lipid droplets are ER-
derived protein and lipid storage organelles targeted by DENV
structural protein C49; therefore, the dysregulated cholesterol
trafﬁcking and accumulation of cholesterol rich lipid droplets
observed in Wolbachia-carrying cells may interfere with proper
localisation of DENV protein C, impairing replication.
Cholesterol-rich lipid droplets were dispersed after 2HPCD
treatment and 2HPCD has been widely used to modulate cho-
lesterol homeostasis; however, it should be noted that 2HPCD
contains a hydrophobic core which may bind to lipids other than
cholesterol.
Overall, the data presented demonstrate that in Ae. aegypti
cells, Wolbachia infection interferes with intracellular cholesterol
trafﬁcking, leads to an accumulation of intracellular cholesterol
stores, perturbs the ER and interferes with vesicular trafﬁcking
and lipid metabolism. Treatment with cyclodextrin provides a
clear indication that these changes are antagonistic to DENV.
Methods
Cell culture. Ae. aegypti Aag2 cells (origin J. Peleg, Israel Institute for Biological
Research, Israel, 1970s; obtained from A. Kohl, Glasgow University) were cultured
at 28 °C in Schneider’s Drosophila medium (Pan Biotech Ltd) supplemented with
10% fetal bovine serum (FBS; Sigma) and 200 units/ml penicillin 200 μg/ml
streptomycin (Sigma). An Aag2 subline was transinfected with wMelPop Wolba-
chia from Drosophila melanogaster line w1118, as previously described16, 50. Brieﬂy,
wMelPop-infected D. melanogaster embryos were collected and dechorionated
using a 2.1% sodium hypochlorite solution for 2 min. Embryos were rinsed three
times with distilled water, immersed in 70% ethanol for 15 s and washed three
times with phosphate-buffered saline (PBS). Embryos were homogenised in a mini
Dounce homogeniser (Wheaton) using a tight pestle for 2–3 min. Embryo
homogenate was overlaid on 75% conﬂuent Aag2 cells in 12-well plates. Plates were
centrifuged at 2,000×g for 1 h at room temperature (RT) and cells subsequently
incubated for 24 h at 28 °C. Absolute Wolbachia density in the Aag2 wMelPop line
was 106± 30 (s.d., n= 3) Wolbachia surface protein/homothorax (wsp/HTH) as
measured by quantitative PCR (qPCR; see qPCR methods). Vero cells (ECACC
catalogue no. 85020205) were cultured at 37 °C with 5% CO2 in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) (Sigma) with 2 mM L-glutamine and 10% FBS
in a humidiﬁed incubator.
Experimental design and statistical rational. A total of four independent bio-
logical replicates (ﬂasks) were processed, sufﬁcient to estimate differential fold
changes using the LIMMA software package51. Label swapping was performed for
each biological replicate to eliminate systematic label quantiﬁcation bias. Five
independent biological replicates of uninfected and wMel-infected Ae. aegypti
midguts were tandem mass tag (TMT) labelled (Thermo) and processed for mass
spectrometry, sufﬁcient to estimate statistically signiﬁcant fold changes using
ScaffoldQ+ 4.0 (Proteome Software Inc.).
Cell lysis, digestion and peptide labelling. Cells were harvested by scraping at
50% conﬂuency (15 × 106 per replicate, 4 replicates per cell line), washed twice in
PBS and stored at −80 °C. Cell pellets were thawed on ice and lysed in 300 µl 0.2%
PPS silent surfactant (Expedeon) in 50 mM triethylammonium bicarbonate
(TEAB) and vortexed. Lysates were heated at 95 °C for 5 min, cooled on ice and
sonicated with a microtip sonicator 3 times for 10 s each. Protein was measured
using the bicinchoninic acid (BCA) assay (Pierce). Samples were reduced with 5
mM dithiothreitol (DTT) for 30 min at 50 °C and alkylated with 15 mM
2-Chloracetamide for 30 min in the dark. Proteins were digested overnight at 37 °C
with trypsin (Sigma)/protein of 1:75 in the presence of 1 mM CaCl2. PPS surfactant
was cleaved with 0.5% triﬂuoroacetic acid (TFA) for 1 h at RT. Digests were
centrifuged at 18,000×g for 15 min and the supernatant dried. Dried peptides were
resuspended in 1 ml 5% formic acid per quantitation channel. Peptides were stable
isotope dimethyl labelled according to Boersema et al.52. Brieﬂy, labelling was
carried out in 200 mg C18 columns. Columns were ﬁrst conditioned with acet-
onitrile followed by buffer A (0.6% (v:v) acetic acid). Peptides were loaded onto
columns and washed with buffer A before being labelled with 5 × 1 ml of either 4%
(v:v) CH2O, 0.6 M NaBH3CN (light), 4% (v:v) CD2O, 0.6 M NaBH3CN (medium)
or 4% (v:v)13CD2O, 0.6 M NaBD3CN (heavy) in 50 mM sodium phosphate pH 7.4.
Columns were washed with buffer A and peptides eluted with 50% (v:v) acetonitrile
0.6% (v:v) acetic acid. Samples were mixed according to a 1:1 protein ratio and
peptides dried.
Midgut lysis, digestion and peptide labelling. Midguts were dissected from 10-
day-old non-blood-fed female Ae. aegypti and immediately frozen at −80 °C. For
each line (uninfected or wMel infected), midguts from 20 mosquitoes were used for
a biological replicate. Midguts were lysed by sonicating 3 × 15 s in 8M urea and 50
mM TEAB. Protein was measured by BCA assay (Pierce). Samples were reduced
with 5 mM DTT for 30 min at 50 °C and alkylated with 15 mM Iodoacetamide for
30 min in the dark. Urea was diluted to 1.5 M with 50 mM TEAB and trypsin/Lys-
C (Promega) added at an enzyme/protein ratio of 1:25. Proteins were digested
overnight at 37 °C. Digests were acidiﬁed with addition of TFA to 0.5% (v:v) and
clariﬁed by centrifugation for 7 min at 18,000×g. Peptides were desalted using
Strata 50 mg C18 cartridges (Phenomenex). Cartridges were prepared by passing
through 3 ml acetonitrile, 2 ml aqueous 80% (v:v) acetonitrile 0.1% (v:v) TFA and
2 ml aqueous 0.1% (v:v) TFA. Peptides were loaded and cartridges washed with 2 ×
0.25 ml aqueous 0.1% TFA. Peptides were eluted with aqueous 80% (v:v) acet-
onitrile 0.1% (v:v) TFA and dried. Peptides were resuspended in 50 mM TEAB at a
concentration of 43 µg/100 µl. A 100 µl aliquot of peptide solution from each
sample was labelled using TMT reagents (TMT-10plex, Thermo Fisher). For each
sample, 0.8 mg of TMT reagent was resuspended in 41 µl acetonitrile and added to
peptides, and labelling took place over 1 h at RT. Excess labelling reagent was
quenched with 8 µl aqueous 5% (v:v) hydroxylamine for 15 min at RT. Labelled
peptides were dried prior to high pH reversed-phase fractionation.
Peptide fractionation. Labelled peptides from cell line digests were fractionated by
OFFGEL peptide fractionation, carried out according to the manufacturer’s
instructions. Brieﬂy, peptides were resuspended in 720 µl water per replicate and
mixed with OFFGEL solution containing pH 3-11 ampholytes. Then, 3 mg of
peptide was fractionated into 24 wells over a 24 cm pH 3-11 immobilised pH
gradient strip. Fractions were acidiﬁed with 0.1% formic acid and desalted with
StageTips.
Labelled peptides from midgut digests were fractionated using high pH
reversed-phase spin columns according to the manufacturer’s instructions (Pierce).
Column was washed twice with 300 µl acetonitrile and twice with aqueous
0.1% (v:v) TFA. Peptides were resuspended in 300 µl aqueous 0.1% (v:v) TFA and
applied to the column by centrifugation for 2 min at 3,000×g. Peptides were washed
with 300 µl water, then 300 µl 5% acetonitrile 0.1% triethylamine and eluted with
300 µl each of aqueous (v:v) 10, 12.5, 15, 17.5, 20, 22.5, 25, 50% acetonitrile 0.1%
triethylamine. Fractions were dried down for analysis by mass spectrometry.
Mass spectrometry. Peptides from cell line samples were resuspended in 0.1%
formic acid and resolved on a C18 reverse-phase PepMap RSLC 50 cm × 75 µm×2
µm, 100 Å Easy-Column (Thermo Scientiﬁc) using a linear gradient of 5–55%
Buffer B (aqueous 80% (v:v) acetonitrile, 0.1% (v:v) formic acid) at 300 nl/min over
130 min run on an Ultimate 3000 RSLC nano (Dionex) system coupled to QEx-
active mass spectrometer (Thermo Scientiﬁc). The mass spectrometer was operated
in a ‘Top 10’ data-dependent acquisition mode with dynamic exclusion enabled
(40 s). Survey scans (mass range m/z 300–1,650) were acquired at a resolution of
70,000 at 200 Th with the 10 most abundant multiply charged (+2 and +3) ions
selected with a 3 Th isolation window for high-energy collisional dissociation
(HCD) fragmentation. Tandem mass spectrometry (MS/MS) scans were acquired
at a resolution of 17,500 at 200 Th.
Peptides from midgut samples were resuspended in 0.1% formic acid and
loaded onto an UltiMate 3000 RSLCnano HPLC system (Thermo) equipped with a
PepMap 100 Å C18, 5 µm trap column (300 µm× 5mm, Thermo) and a PepMap, 2
µm, 100 Å, C18 Easy Nanonanocapillary column (75 μm× 150 mm, Thermo). The
trap wash solvent was 0.05% (v:v) aqueous TFA and the trapping ﬂow rate was 15
µl/min. The trap was washed for 3 min before switching ﬂow to the capillary
column. Separation used gradient elution of two solvents: solvent A, aqueous 1%
(v:v) formic acid; solvent B, aqueous 80% (v:v) acetonitrile containing 1% (v:v)
formic acid. The ﬂow rate for the capillary column was 300 nl/min and the column
temperature was 40 °C. The linear multi-step gradient proﬁle was: 3–10% B over 8
min, 10–35% B over 125 min, 35–65% B over 50 min, 65–99% B over 7 min and
then proceeded to wash with 99% solvent B for 4 min. The column was returned to
initial conditions and re-equilibrated for 15 min before subsequent injections.
The nanoLC system was interfaced with an Orbitrap Fusion hybrid mass
spectrometer (Thermo) with an EasyNano ionisation source (Thermo). Positive
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electrospray ionisation (ESI)-MS, MS2 and MS3 spectra were acquired using
Xcalibur software (version 4.0, Thermo). Instrument source settings were: ion spray
voltage, 1,900 V; sweep gas, 0 Arb; ion transfer tube temperature, 275 °C. MS1
spectra were acquired in the Orbitrap with: 120,000 resolution, scan range: m/z
380–1,500; automatic gain control (AGC) target, 2e5; max ﬁll time, 50 ms. Data-
dependant acquisition was performed in top speed mode using a 4 s cycle, selecting
the most intense precursors with charge states >1. Dynamic exclusion was
performed for 50 s post-precursor selection and a minimum threshold for
fragmentation was set at 3e4. MS2 spectra were acquired in the linear ion trap with:
scan rate, turbo; quadrupole isolation, 1.2m/z; activation type, collision-induced
dissociation; activation energy: 35%; AGC target, 1e4; ﬁrst mass, 120m/z; max ﬁll
time, 50 ms. MS3 spectra were acquired in multi notch synchronous precursor
mode (SPS3), selecting the 5 most intense MS2 fragment ions between 400 and
1,000m/z. SPS3 spectra were measured in the Orbitrap mass analyser using: 50,000
resolution, quadrupole isolation, 2m/z; activation type, HCD; collision energy,
65%; scan range: m/z 110–500; AGC target, 5e4; max ﬁll time, 86 ms. Acquisitions
were arranged by Xcalibur to inject ions for all available parallelisable time.
MS data analysis. MS data ﬁles from cell line samples were de-isotoped and
charge deconvoluted with Proteome Discoverer 1.4 (Thermo). Files were searched
using Mascot 2.4.1 against a concatenated and reversed decoy Ae. aegypti and
Wolbachia wMel database containing 18,082 sequences. Cysteine carbamido-
methylation and protein N-terminal acetylation were set as ﬁxed modiﬁcations.
Oxidation (M), dimethyl (K, N-termini), dimethyl-4 (K, N-termini) and
dimethyl-8 (K, N-termini) were set as variable modiﬁcations. Precursor mass tol-
erance was 20 p.p.m., and fragment mass tolerance was 0.1 Da. Two mis-cleavages
were allowed. Peptide cutoff score was 10 and protein relevance threshold was 20,
false discovery rate (FDR) was 1.23%. The structure of Proteome Discoverer.msf
ﬁles was viewed with DbVisualizer (DbVis Software AB). The ‘Pre-
cursorIonQuanResults’ table was exported. For each peptide with a quantitation
status of ‘used’, the ‘QuanResultID’ was used to obtain light, medium and heavy
peak areas, summed within each ‘QuanChannelID’. For each biological replicate,
proteins with >=3 ‘QuanResultID’ associated were retained. Peptide intensities for
each protein were summed within quantitation channels. Differentially expressed
proteins were determined using LIMMA51, with normalizeWithinArrays (meth-
od=loess) and normalizeBetweenArrays (method=quantile). P-values were calcu-
lated for protein fold changes, adjusted for multiple hypothesis testing with the
Benjamini–Hochberg method53, and fold changes with an adjusted P-value< 0.05
were accepted. From the cell line, 3,785 proteins, representing ~28% of the pro-
teome, were identiﬁed and quantiﬁed in at least 3 biological replicates.
For midgut-derived TMT data peak lists were converted from centroided .raw
to .mgf format using Mascot Distiller (version 2.6.1, Matrix Science) and MS3
spectra were concatenated into their parent MS2 spectra for database searching.
Mascot Daemon (version 2.5.1, Matrix Science) was used to combine .mgf ﬁles and
search against a subset of the UniProt database containing Ae. aegypti and
Wolbachia w Mel proteins (17,811 sequences) using a locally running copy of the
Mascot program (Matrix Science Ltd, version 2.5.1). Search criteria speciﬁed:
Enzyme, trypsin; Fixed modiﬁcations, Carbamidomethyl (C), TMT6plex (N-term,
K); Variable modiﬁcations, Oxidation (M); Peptide tolerance, 5 p.p.m.; MS/MS
tolerance, 0.5 Da; Instrument, ESI-TRAP. The Mascot .dat result ﬁle was imported
into Scaffold Q + (version 4.7.5, Proteome Software) and a second search run
against the same database using X!Tandem was run. Protein identiﬁcations were
ﬁltered to require a maximum protein and peptide FDR of 1% with a minimum of
two unique peptide identiﬁcations per protein. Protein probabilities were assigned
by the Protein Prophet algorithm54. Proteins that contained similar peptides and
could not be differentiated based on MS/MS analysis alone were grouped to satisfy
the principles of parsimony. Proteins sharing signiﬁcant peptide evidence were
grouped into clusters. Quantiﬁcation of relative protein abundance was calculated
from TMT reporter ion intensities using Scaffold Q +. TMT isotope correction
factors were taken from the document supplied with the reagents by the
manufacturer. Normalisation was performed iteratively (across samples and
spectra) on intensities, as described in ref. 55. Medians were used for averaging.
Spectra data were log-transformed, pruned of those matched to multiple proteins
and weighted by an adaptive intensity weighting algorithm. Differentially expressed
proteins were determined by applying permutation test with unadjusted
signiﬁcance level p< 0.05 corrected by Benjamini–Hochberg for FDR estimation.
The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium56 via the PRIDE partner repository with the data
set identiﬁer PXD003429 (Aag2 cell data) or PXD006239 (midgut data).
Cholesterol quantiﬁcation. Aag2 cells stably infected with wMelPop and a
rifampicin cured negative line were grown to conﬂuency in six-well plates. Cells
were washed twice with PBS prior to harvesting by scraping. In all, 12 wells of each
cell type were harvested for cholesterol measurements. Then, 200 µl of hexane/
isopropanol 3:2 was added to the cell pellet from half a well to extract cholesterol.
Extracts were centrifuged at 10,000×g for 5 min at RT, the supernatant was dried in
a vacuum centrifuge overnight and extracts resuspended in 100 µl reaction buffer
(0.1 M potassium phosphate pH 7.4, 0.05M NaCl, 5 mM cholic acid, 0.1% Triton
X-100, Thermo Fisher). Free cholesterol was quantiﬁed using the Amplex Red
Cholesterol Assay Kit (Thermo Fisher), and esteriﬁed cholesterol was quantiﬁed by
including cholesterol esterase in the reactions. Cholesterol quantities were nor-
malised to total input protein. Input protein was measured by resuspending the
protein pellet left after hexane/isopropanol cholesterol extraction in 100 µl RIPA
buffer (Sigma). Protein content was measured using the BCA assay (Thermo
Scientiﬁc).
Imaging. Uninfected and infected wMelPop Aag2 cells were seeded at 3 × 105 cells/
well in 1 ml FBS and penicillin/streptomycin supplemented Schneider’s Drosophila
medium in a 24-well poly-L-lysine-coated plate and allowed to adhere overnight.
Cholesterol was labelled according to Sankaranarayanan et al.57; brieﬂy, labelling
media was prepared by adding 3.47 ml of 20 mM methyl-beta-cyclodextrin (Sigma)
in unsupplemented Schneider’s Drosophila medium to 1 mg of 23-(dipyrro-
metheneborondiﬂuoride)-24-norcholesterol (TopFluor cholesterol, Avanti Polar
Lipids) to achieve a 1:40 cholesterol/cyclodextrin molar ratio. This mixture was
sonicated for 6 × 5 s pulses. The sample was then centrifuged at 19,000×g for 10
min to remove undissolved cholesterol. TopFluor cholesterol was then diluted 1:1
in unsupplemented Schneider’s Drosophila medium. This was then added to the
cells and incubated for 30 min to allow labelling to occur. Labelling media were
then removed and either PBS or 0.1 mM of 2HPCD was added. After 48 h, the cells
were washed with PBS before Vecta shield mounting media with 4',6-diamidino-2-
phenylindole (DAPI; Vectorlabs) was added. Images were then acquired using a
Zeiss LSM 880 confocal microscope (Zeiss) with a 63× objective. Cholesterol was
imaged using a 488 nm laser, with GaAsP detectors. Nuclei stained with DAPI were
imaged using a 405 nm laser with GaAsP detector. All settings were obtained by
ﬁrst imaging uninfected Aag2 cells incubated in PBS as a standard control ensuring
all data were correlated. Z-stack images were collected and analysed using
Zen2 software (Zeiss) to create a 3D reconstruction of imaged cells after de-
convolution was carried out.
Quantiﬁcation was carried out by imaging 5 independent ×64 images from 5
independent wells on a 24-well optical plate. Images were analysed using Cell
Proﬁler. A global image threshold was set using the Otsu method and images were
analysed in order to identify the number of nuclei and the number of green spots
corresponding to TopFluor staining. Data are presented as the number of spots per
cell.
For Rab7 staining, Aag2 wMelPop cells were ﬁxed with 2.5% paraformaldehyde
and permeabilised in PBS containing 0.01% Triton-X for 15 min. Cells were
blocked for 1 h with 5% serum before incubation with Rab7 antibody (Abcam,
ab50533, 1:500). Images were obtained as stated above.
For Nile Red staining, cells were ﬁxed and permeabilised as above. Cells were
then incubated for 10 min in 10 µg/ml of Nile Red. Nile Red is known to ﬂuoresce
in green/yellow where lipid droplets are present39. Images were then acquired using
a Zeiss LSM 880 confocal microscope (Zeiss) with a 63× objective as above with the
514 laser. Images were processed in Zen blue and lipid droplets measured.
DENV-2 propagation, infection and quantiﬁcation. DENV-2 New Guinea C
strain (Public Health England, 0006041v), propagated in Vero cells, was diluted
1:100, one round of propagation was carried out in C6/36 cells (ECACC catalogue
no. 89051705) for 5 days and the resulting virus stock was centrifuged for 7 min at
400×g and quantiﬁed by ﬂuorescent focus assay (FFA)58. For the FFA, Vero cells
were plated at a density of 0.9 × 105 cells/well in 96-well special optics plates
(Corning). The following day, 10-fold serial dilutions of DENV containing
supernatant were prepared using DMEM with 2% FBS. Medium was removed from
Vero cells and 50 µl of each serial dilution was added to wells. Plate was placed on
an orbital shaker at 20 r.p.m. and left at 37 °C for DENV to bind for 45 min. DENV
was removed and 150 µl of overlay medium/well (DMEM with 0.8% carbox-
ymethylcellulose, 5% FBS, 2 mM L-glutamine, 200 units/ml penicillin 200 µg/ml
streptomycin) was added. Plates were left for 48 h, overlay medium was removed
and cells washed twice in PBS. Cells were ﬁxed with methanol for 10 min at 4 °C,
washed with 150 µl PBS and permeabilised for 5 min with 150 µl 0.1% Triton X-100
(Fisher). Permeabilisation solution was removed and 35 µl of 1:500 anti-DENV
antibody was added (MAB8705, Millipore), diluted in 0.2% bovine serum albumin
(BSA) PBS. Plates were incubated for 1.5 h at RT, followed by 3 washes of 100 µl
with 0.2% BSA PBS. Cells were incubated with 35 µl of 1:400 secondary antibody
(Goat anti-mouse Alexa Fluor 488, A-11001, Thermo Fisher) in 0.2% BSA PBS for
1 h at RT. Cells were washed 3 times with 0.2% BSA PBS and ﬂuorescent foci were
counted using a ﬂuorescent microscope or plates were imaged with a Typhoon FLA
9500 scanner using ﬁlter settings for Cy2. Plate images were processed in ImageJ,
the ‘Analyze Particles’ feature was used to count ﬂuorescent foci.
For the DENV rescue experiments, Aag2 cells were seeded in 96-well tissue
culture plates (Corning) at a density of 150,000 cells/ml. The next day treatment
commenced with 2-hydroxypropyl-β-cyclodextrin (Sigma) at the indicated
concentrations in cell culture medium. After 48 h of treatment, cell culture medium
was removed, cells were washed with 100 µl PBS and DENV was added in
Schneider’s Drosophila medium without FBS at a multiplicity of infection of 0.1 in
a volume of 35 µl/well. Plates were placed on an orbital shaker set at 20 r.p.m. for 2
h at RT. Virus was removed and normal Schneider’s Drosophila medium was
added with 10% FBS and 200 units/ml penicillin 200 μg/ml streptomycin (Sigma).
Plates were incubated at 28 °C for 5 days after which cells were harvested in 100 µl
Tri reagent (Sigma) and RNA extracted as described below. For quantiﬁcation of
DENV by FFA, supernatant was harvested 7 days post infection.
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Mosquito line and rearing. A wMel-infected Ae. aegypti line was created by
microinjecting wild-type embryos from a Malaysian-derived line with cytoplasm
from an Indonesian-derived (UJU) wMel Ae. albopictus line6. The line was out-
crossed with males of the wild-type line for three generations, and maintained
for ∼20 generations. Wolbachia density in the wMel line midguts was 7.8 + –4.6 (S.
D., n= 5) Wolbachia surface protein/homothorax (wsp/HTH) as measured by
qPCR (see below). Maternal transmission was 100% as determined by PCR. Ae.
aegypti wild type and wMel-infected lines were maintained at 27 °C at 70%
humidity.
RNA/DNA extraction and qPCR. For estimation of Wolbachia density, DNA was
extracted using phenol/chloroform from three independent samples of the Aag2
wMelPop cell line. Absolute Wolbachia density was measured by qPCR using
primers targeting wsp (forward: 5′-GCATCTTTTATAGCTGGTGG-3′, reverse:
5′-AAAGTCCTTCAACATCAACCC-3′, normalised to host HTH (forward:
5′-TGGTCCTATATTGGCGGAGCTA-3′, reverse: 5′-TCGTTTTTGCAA-
GAAGGTCA-3′)16. Relative Wolbachia density in the 2HPCD experiments was
measured by qPCR using primers targeting wsp, normalised to host rp49 (forward:
5′-GCTATGACAAGCTTGCCCCCA-3′, reverse: 5′-TCATCAGCACCTC-
CAGCTC-3′)59.
Data availability. The data from mass spectrometry are deposited at the Proteo-
meXchange Consortium via the PRIDE partner repository with the data set
identiﬁers PXD003429 and PXD006239. The authors declare that all other data
supporting the ﬁndings of this study are available within the article and its Sup-
plementary Information ﬁles, or are available from the authors on request.
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